Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast
RATIONALE: Studying samples of breast tissue in the laboratory may help doctors learn more about the genes and proteins found in breast tissue.
PURPOSE: This phase I trial is studying genes and proteins in breast tissue from women undergoing surgery for breast cancer or core biopsy of the breast.
|Breast Cancer||Genetic: microarray analysis Procedure: breast biopsy||Phase 1|
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Pilot Study for Analysis of Tumor Gene Expression by DNA Microarray Analysis in Patients Undergoing Breast Cancer Surgery or Core Biopsy Sampling|
- Tumor gene expression as assessed by DNA microarray analysis [ Time Frame: 1 year ]tumor sample will be assessed by DNA microarray
|Study Start Date:||September 1999|
|Estimated Study Completion Date:||December 2016|
|Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
Genetic: microarray analysis
- Assess tumor gene expression information from women undergoing surgery for breast cancer or core biopsy sampling of the breast.
OUTLINE: This is a pilot study.
Tumor tissue is collected and analyzed for tumor gene expression by DNA microarray analysis for research studies.
PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00898937
|United States, District of Columbia|
|Lombardi Comprehensive Cancer Center at Georgetown University Medical Center|
|Washington, District of Columbia, United States, 20007|
|Principal Investigator:||Claudine Isaacs, MD||Lombardi Comprehensive Cancer Center|